Helsinki University Central Hospital
Helsinki, Uusimaa, 00029, Finland
NCT Number: NCT02369991
This study assesses the long-term results of compound tibial reconstruction treated with a microvascular latissimus dorsi flap and bone transport technique during the last 25 year in Helsinki University central Hospital.
Looking for future studies?
Notify Me15 year and older
All sexes
Observational
Helsinki, Uusimaa, 00029, Finland
A retrospective review of hospital records was conducted to chart the clinical and operational characteristics of patient. Patients current condition is assessed by applying two function-related (Disabilities of the Arm, Hand and Shoulder, DASH; Lower Extremity Functional Scale, LEFS) and a health-related quality of life (the 15-dimensions, 15D) questionnaires. The patients received the questionnaires by mail. A written informed consent was obtained from the participants. The obtained data was computerized and analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients were treated with free latissimus dorsi flap and bone transport technique
Time frame: 10-25 years
Assesses the function of the donor site
Time frame: 10-25 years
Assesses the HRQoL
Time frame: 10-25 years
Assesses the function of the reconstructed limb
Helsinki University Central Hospital
Other
Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique: a Cross-sectional Study of Long-term Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03712995
Reconstructive Surgical Procedure
View Trial DetailsNCT07338006
Chest Wall Tumor, Malignancy
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07625709
Blood Loss, Postoperative, Blood Loss, Surgical
Dhulikhel, Bagmati, Nepal
View Trial DetailsNCT07554079
Antibiotic, Antibiotic Prescription
Dhulikhel, Bagmati, Nepal
View Trial Details